K-ECAN Tool Can Predict Esophageal, Gastric Cardia Adenocarcinoma
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 28, 2023 -- The Kettles Esophageal and Cardia Adenocarcinoma predictioN (K-ECAN) Tool can predict incident esophageal adenocarcinoma (EAC) and gastric cardia adenocarcinoma (GCA) using electronic health record data, according to a study published online Aug. 17 in Gastroenterology.
Joel H. Rubenstein, M.D., from the LTC Charles S. Kettles Veterans Affairs Medical Center in Ann Arbor, Michigan, and colleagues accessed the Veterans Health Administration (VHA) Corporate Data Warehouse to identify veterans with one or more encounters between 2005 and 2018. Cases diagnosed with EAC or GCA (8,430 and 2,965, respectively) were compared to 10,256,887 controls. The K-ECAN Tool was developed and validated internally using a machine learning method. Training, preliminary validation, and final testing was performed in 50, 25, and 25 percent of the data, respectively.
The researchers found that compared with previous models such as HUNT and Kunzmann or published guidelines, K-ECAN was well calibrated and had better discrimination (area under the receiver operating characteristic curve [AuROC], 0.77 versus 0.68 and 0.64, respectively). The accuracy was slightly attenuated using only data between three and five years before index (AuROC, 0.75). The AuROCs of HUNT and Kunzmann improved on undersampling men to simulate a non-VHA population, but K-ECAN was still the most accurate (AuROC, 0.85). Gastroesophageal reflux disease was strongly linked to EAC, but contributed a small proportion of gain in information for prediction.
"Our devoted team was able to use sophisticated machine learning tools to develop this unique tool, and we are very excited that this could potentially lead to increased screening and a decrease in preventable deaths," Rubenstein said in a statement.
Two authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
First Responders With More Debris Exposure Have Higher Risk of Early Dementia
FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...
1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM
FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...
Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy
FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.